Fifth Third Bancorp’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,441
Closed -$196K 2303
2016
Q4
$196K Sell
2,441
-250
-9% -$19.8K ﹤0.01% 914
2016
Q3
$215K Sell
2,691
-698
-21% -$56.4K ﹤0.01% 893
2016
Q2
$264K Buy
3,389
+800
+31% +$57K ﹤0.01% 857
2016
Q1
$142K Sell
2,589
-1,674
-39% -$91.2K ﹤0.01% 1003
2015
Q4
$263K Sell
4,263
-172
-4% -$10.8K ﹤0.01% 885
2015
Q3
$280K Buy
4,435
+177
+4% +$12.6K ﹤0.01% 887
2015
Q2
$311K Sell
4,258
-90
-2% -$6.5K ﹤0.01% 870
2015
Q1
$284K Buy
4,348
+245
+6% +$16.3K ﹤0.01% 903
2014
Q4
$267K Sell
4,103
-88
-2% -$5.67K ﹤0.01% 888
2014
Q3
$252K Buy
4,191
+13
+0.3% +$849 ﹤0.01% 900
2014
Q2
$289K Sell
4,178
-262
-6% -$17K ﹤0.01% 877
2014
Q1
$290K Sell
4,440
-469
-10% -$30.5K ﹤0.01% 843
2013
Q4
$304K Buy
4,909
+3,615
+279% +$209K ﹤0.01% 826
2013
Q3
$69K Buy
1,294
+56
+5% +$2.88K ﹤0.01% 1167
2013
Q2
$56K Buy
+1,238
New +$53.6K ﹤0.01% 1255

Other funds holding STJ

Fifth Third Bancorp's STJ Position: Q1 2017 in Review

Fifth Third Bancorp sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,441 shares — an estimated $196K sold.

Fifth Third Bancorp first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $311K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Fifth Third Bancorp reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Fifth Third Bancorp sold 2,441 St Jude Medical shares in Q1 2017, an estimated $196K.
  • Fifth Third Bancorp first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Fifth Third Bancorp's St Jude Medical position peaked at $311K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Fifth Third Bancorp's 13F filing for Q1 2017, filed 12 May 2017.